Abstract
Entosis is cell cannibalism utilized by tumor cells to engulf live neighboring cells for pro- or anti-tumorigenic purposes. It is unknown whether this extraordinary cellular event can be pathogenic in other diseases such as microcephaly, a condition characterized by a smaller than normal brain at birth. We find that mice mutant for the human microcephaly-causing gene Pals1, which exhibit diminished cortices due to massive cell death, also exhibit nuclei enveloped by plasma membranes inside of dividing cells. These cell-in-cell (CIC) structures represent a dynamic process accompanied by lengthened mitosis and cytokinesis abnormalities. As shown in tumor cells, ROCK inhibition completely abrogates CIC structures and restores the normal length of mitosis. Moreover, genetic elimination of Trp53 produces a remarkable rescue of cortical size along with substantial reductions of CIC structures and cell death. These results provide a novel pathogenic mechanism by which microcephaly is produced through entotic cell cannibalism.
Similar content being viewed by others
Introduction
Cell competition refers to homeostatic processes that eliminate undesirable cells1. Competition by cannibalism, called entosis, describes engulfment by neighboring cells resulting in cell-in-cell structures2. This unusual cellular event is often found in epithelial tumors with poor prognosis but is rare in normal contexts3,4,5,6,7. Although first reported in tumor cells in which epithelial cell-matrix detachment is a major driving force, entosis is also found in attached cells that are actively undergoing mitosis8,9. Because asymmetric contractility due to Rho-ROCK activation within the phagocytosed cells drives invasion into host cells, mitotic cells with imbalanced contractility are postulated to underlie entosis in dividing cells10,11,12,13. Factors involved in regulating RhoA-ROCK signaling, such as the polarity complex proteins, CDC42 and PCDH7, have been implicated in the emergence of entosis, while upregulation of DNA damage and the P53 tumor suppressor protein are also known to contribute to the process9,11,12,13,14,15,16. However, it is unclear whether entosis can occur in pathogenic processes other than cancer, such as neurodevelopmental disorders. Much like tumor cells, neural progenitors undergo massive proliferation, though they must adhere to exacting requirements for division, including faithful segregation of genetic constituents. Due to the importance of cell division in cortical development, many genes required for mitotic progression are linked to microcephaly, a condition in which patients are born with small brains17,18,19,20,21. Importantly, activation of P53, one of the major means by which genome-compromised cells are eliminated, is known to contribute to the pathogenesis of microcephaly22,23,24,25,26,27. Despite the critical importance of these issues, whether entosis occurs in neural progenitors and whether P53 activation in pathological conditions contributes to entosis, remain unknown.
Here, our studies of Pals1, a human microcephaly-causing gene, show that an entosis-like process (hereafter referred to as entosis) results in engulfed cells that are visible within dividing cortical progenitors. We find that as in tumor cells, this entosis produces dynamic and mobile cellular entities that are highly associated with lengthened mitosis, chromosomal defects, and abnormal cytokinesis in Pals1 mutants. As in described forms of entosis, ROCK inhibition abrogates entosis and restores normal mitotic length, revealing the importance of Rho-ROCK dysregulation in this phenotype. We find that P53 is highly activated in Pals1 mutants and through genetic deletion of Trp53, we show the critical role of P53 activation in massive apoptotic cell death, lengthened mitosis, and entotic engulfment that leads to reduced cortical size. Together, our results uncover a previously unrecognized cellular mechanism, entosis, in the pathogenesis of microcephaly and reveal the essential role of P53 activation in this process.
Results
Entosis is caused by PALS1 loss
Remarkably, while investigating the pathogenic mechanism of microcephaly due to mutation of the gene encoding PALS1 (protein associated with LIN7, also known as MPP5), a component of the CRB apical polarity complex, with either of two Cre drivers (hGFAP-Cre, or Emx1-Cre), we identified nuclei enclosed by cell membranes inside cells at the ventricular surface of the developing cortex (Fig. 1a, b, Supplementary Fig. 1, Supplementary Movie 1)28,29. It has been shown previously that Pals1 mutation causes microcephaly in humans and that its cortex-specific deletion generates mice lacking a cortex due to massive cell death30,31,32,33,34. To determine whether the plasma membrane-enclosed nuclei observed inside mitotic host cells are cell-in-cell (CIC) structures, we analyzed these structures with static as well as time-lapse imaging. To visualize cellular dynamics, we used en face preparations of ex vivo cortical explant cultures at embryonic day (E)14.5 to track the progression of mitosis in apical progenitors from their appearance at the apical surface in prophase to observable membrane separation in telophase (Fig. 1a, c). We utilized a ROSAmTmG reporter line to visualize the membrane of Cre recombined cells and labeled DNA with SiR-DNA (Spirochrome). Surprisingly, close examination revealed obvious GFP-labeled plasma membrane-encircled nuclei in 45% of PALS1-deficient mitotic cells in Pals1 cKO; hGFAP-Cre mice, but none in control animals (Fig. 1c, d, Supplementary Movie 2, 3, 4).
To provide evidence that these CIC structures are generated through entosis, we sorted those found in mitotic cells into three categories (Fig. 1e). Entosis is a highly dynamic cellular process shown to have a variety of potential outcomes2,8,10,11. Daughter cell engulfment is an initiating step in CIC formation: 23% of observed CIC structures showed this initial step of entosis. CIC persistence, in which an internalized cell remains within the parent cell for the duration of mitosis, was present in 57% of cases. Lastly, the expulsion of the inner cell (inner cell escape) can occur at any point during the mitotic cycle and was observed in about 19% of CIC structures in our experiments (Fig. 1f). These results suggest that small, internalized cells are highly dynamic structures generated through entotic engulfment and that, by E14.5, a large proportion of entotic structures have already been engulfed and are persisting within outer cells.
CIC structures interfere with cytokinesis
Next, because a high proportion of mitotic cells include CIC structures, we examined the cellular consequences of persistent entotic cells and how they contribute to the pathology of microcephaly in Pals1 mutants. Genetic deletion of Pals1 in the cortical progenitors of hGFAP-Cre mice starts at E12.5, an early timepoint in cortical neurogenesis, and produced cortices half the normal size, in which numbers of layer-specific neurons, especially late born neurons, were reduced (Supplementary Fig. 2). Consistent with previous models, progenitor populations were reduced, and cell death increased (Supplementary Fig. 3, 4). Because massive cell death is a hallmark of PALS1 cortical deficiency and entosis is a mechanism for eliminating unfit cells, we examined apoptotic cell death via cleaved caspase (CC)3 and DNA damage via γH2AX in mitotic cells which typically host CIC structures. We marked dividing cells with phosphorylated histone (PH)3 or MPM2 immunostaining to determine whether they undergo apoptotic cell death or display DNA damage. We found that the proportion of mitotic neural progenitors undergoing apoptosis or displaying DNA damage is very low in the Pals1 mutants (Supplementary Fig. 5). Additionally, we failed to detect instances of CIC structures displaying DNA damage or apoptosis, consistent with reports that CIC structures are often cleared by autophagy2,8,10. This result indicates that most apoptotic cells are not inner cells nor currently dividing outer cells (Supplementary Fig. 5), suggesting that abundant apoptotic cells found in Pals1 mutants could reflect the consequences of defects caused by entosis and mitotic disruption, but are not CIC themselves.
Although CIC structures are likely to be eliminated by autophagy, those that persist can interfere with cell division, as shown in tumor cells, leading to mitotic delay, mitotic arrest, or abnormal genomic content10,34,35. Therefore, we studied these cells with extensive time-lapse imaging. This imaging revealed significantly lengthened mitosis in Pals1 cKO cells: the average time to complete mitosis (prophase to telophase) increased to 67 min (median: 65 min), compared to only 52 min in wild-type (WT) progenitors (median: 50 min) (Fig. 1g). This result is consistent with previous reports19,20. Importantly, when comparing only PALS1-deficient progenitors with or without CIC structures, the presence of CIC was strongly correlated to longer mitotic length; cells with CIC structures required an average of 76 min to undergo mitosis (median: 80 min) compared to only 55 min for cells without CIC structures (median: 60 min) (Fig. 1h). Similarly, the proportion of time allocated for metaphase through cytokinesis to total mitotic length was also larger in PALS1-deficient progenitors, suggesting that cytokinesis is defective (Fig. 1i).
Because time-lapse imaging demonstrated significant mitotic delay, we investigated cellular deficits related to mitosis in further detail. First, we performed transmission electron microscopy (TEM) and found that there were no obvious defects in junctions or cilia at the ventricular surface at E13.5 (Supplementary Fig. 6). However, PALS1-deficient mitotic cells were in cytokinesis more frequently than those of WT littermates, with only 1 out of 15 observed mitotic cells in cytokinesis in WT (6%) compared to 9 out of 24 cells (37.5%) in cytokinesis in Pals1 mutants (Supplementary Fig. 6). Pals1 mutant cells undergoing cytokinesis displayed micronuclei and lagging chromosomes, characterized by DNA not enclosed in a plasma membrane, clearly indicating profound mitotic defects. Because TEM analysis was conducted one day prior to time-lapse imaging where we detect numerous membrane-enveloped CIC structures, micronuclei may represent an initial event that leads to CIC formation (Fig. 2a).
Next, to analyze the impact of CIC structures on mitosis, we carried out mitosis analyses at E14.5. When we used PH3 immunostaining to analyze cells at the ventricular surface undergoing each phase of mitosis at E14.5 in PALS1-deficient mice, we consistently found an increased proportion of mitotic cells in anaphase and telophase compared to those of WT littermates (Fig. 2b, c, Supplementary Fig. 7a–d). Interestingly, even though outer cells are PH3-positive mitotic cells, inner cells do not express PH3, indicating that they are not undergoing mitosis (Fig. 2b). Paired with the evidence of CIC structures from time-lapse imaging, these data suggest that CIC structures may interfere with cytokinesis in PALS1-deficient outer cells. Because entosis is known to affect cytokinesis by hampering cleavage furrow ingression and cell severing, we examined the structures essential for cytokinetic division, the actomyosin-based cleavage furrow and midbody35,36,37,38. We visualized the actomyosin contractile ring enclosing the cleavage furrow with non-muscle myosin 2b (NMIIB) immunostaining and labeled midbodies with SURVIVIN immunostaining in cortical explants. NMIIB staining revealed that the height of the cleavage furrow was doubled in PALS1-deficient progenitors, suggesting that the contractile ring is larger than that of WT cells (Fig. 2d, e). Visualization of the 3D structure with z-stacked images through IMARIS confirmed that the cleavage furrow was enlarged. Furthermore, our 3D analyses of midbodies labeled by SURVIVIN showed that whereas midbodies in WT cells were approximately equidistant from each daughter nucleus, midbody positioning in Pals1 cKO cells was off-center and often associated with micronuclei possessing no enveloping plasma membrane, and membrane-enveloped CIC structures (Fig. 2f, g). To confirm that entosis is a common outcome of PALS1 loss, we also examined Pals1 mutant animals with Emx1-Cre. Although the cortex was completely abrogated in homozygotes, heterozygote mutants showed reductions of cortical size and cortical progenitors30. Emx1-Cre; Pals1 heterozygous cKO mice showed similar cytokinesis defects to the Pals1; hGFAP-Cre cKO, including enlarged cleavage furrows and shifted midbody positioning (Supplementary Fig. 7). Taken together, our results demonstrate that both micronuclei and CIC structures may hinder cytokinesis, resulting in lengthened mitosis and potentially contributing to impaired cellular viability.
Because Rho-ROCK hyperactivation drives entosis, we next tested whether inhibition of ROCK can eliminate CIC structures and restore the length of mitosis in PALS1-deficient neural progenitors in Emx1-Cre; Pals1 heterozygous cKO mice38. To this end, we injected pregnant dams with 10 mg/kg of ROCK inhibitor Y-27632 at E12.5, harvested embryonic cortices at E13.5, cultured them overnight with 10 µM Y-27632, and then performed time-lapse imaging (Fig. 2h). When ROCK inhibitor was introduced to WT animals, the average time to undergo mitosis was unchanged (mean: 53 min, median: 50 min), suggesting that ROCK inhibition does not alter timely mitotic progression in WT cells. When heterozygous Pals1 cKO cortices were treated with ROCK inhibitor, the average time to undergo mitosis was significantly reduced from 67 min (median: 70 min) to 52 min (median: 65 min) and CIC structures were absent, suggesting a full rescue of both phenotypes (Fig. 2i–k, Supplementary Movie 5, 6, 7). These rescue effects are also consistently found in the Pals1; hGFAP-Cre cKO. This provides strong evidence that CIC structures are generated by entosis and that mitotic delay in Pals1 mutant progenitors is due to their interference with completion of cytokinesis.
P53 activation amplifies entosis and causes massive cell death
To understand the molecular mechanism triggering entosis, we examined the activation of P53 and its contribution to generating CIC structures and mitotic defects. P53 is a promising candidate as the pathogenic mediator in these processes because delays in mitotic progression, such as those observed in PALS1-deficient cortical progenitors, can activate P5320,39. P53 activation has been implicated in several genetic models of microcephaly in which elimination of P53 prevents apoptotic cell death, restoring brain size to some extent22,23,24,25,26,27. Importantly, by altering Rho-ROCK activity40,41, P53 is also thought to play a role in entosis to eliminate aneuploid cells14,15. We reasoned that micronuclei found in Pals1 mutants with reduced genomic content may activate P53 and induce entosis. To test whether P53 is activated in the Pals1 cKO cortex, we performed RNAScope for P21, an established transcriptional target of P5342, and assessed P53-dependent activation of phagocytic microglia which clear apoptotic cells27. Consistent with P53 activation, P21 transcripts were significantly elevated in Pals1 mutants and the number of F4/80+ activated microglia increased (Fig. 3a–d, Supplementary Fig. 3a-d). Importantly, genetic elimination of Trp53 in PALS1-deficient cortices fully rescued elevated P21 levels and reduced the number of F4/80+ activated microglia, further demonstrating that their activation is P53 dependent.
Next, to examine whether the Rho-ROCK pathway is abnormally activated in Pals1 mutants and whether Trp53 deletion can decrease its activation, we used pMLC (S19) immunostaining to monitor activated myosin. Activated myosin at the apical surface of the cortex is significantly increased when PALS1 is reduced during neurogenesis (Fig. 3e, f, Supplementary Fig. 8a, b). Consistent with reports that P53 activation can increase Rho-ROCK signaling14,40,41, Trp53 co-deletion significantly reduced activated myosin levels at the cortical ventricular surface. This data suggests that Rho-ROCK signaling is altered in the Pals1 cKO largely due to P53 activation.
This result prompted us to determine if P53 activation is involved in the emergence or persistence of CIC structures. We found that as in the Pals1; hGFAP-Cre cKO, 43% of mitotic neural progenitors in Pals1; Emx1-Cre heterozygote cKO mice had CIC structures whereas no WT cells exhibited entosis. Importantly, Trp53 co-deletion significantly reduced the occurrence of CIC structures in Pals1 mutants (Fig. 3g–i, Supplementary Fig. 8c–f, Supplementary Movie 8, 9, 10). Remarkably, Trp53 co-deletion reduced the proportion of mitotic cells with entosis to 15%, significantly less than the 43% found in the Pals1 cKO. Additionally, while heterozygous Pals1 deletion increased the average time to undergo mitosis to 67 min (median:70 min), Trp53 co-deletion significantly reduced mitotic length back to 61 min (median: 60 min). Defects in cytokinesis machinery, such as cleavage furrow height and midbody placement, were also substantially improved. While heterozygous Pals1 deletion increased the mean cleavage furrow height from only 2 µm in WT cells to 4 µm, Trp53 co-deletion reduced the average cleavage furrow height to 3 µm. Additionally, midbodies were off-center 45% of the time in heterozygous Pals1 deletion but only 15% in WT. When Trp53 was co-deleted, midbodies were off-center 25% of the time (Supplementary Fig. 7e-g). Collectively, these results show that the genetic elimination of Trp53 significantly ameliorates PALS1-dependent mitotic defects, including entosis, suggesting that P53 plays an important role.
Because Trp53 co-deletion significantly improved mitotic defects, we next studied the effects of Trp53 co-deletion on cell survival and cortical development. The dosage dependence of Pals1 loss allowed us to observe the effects of Trp53 co-deletion in both homozygous and heterozygous animals. Profound apoptosis and DNA damage are hallmarks of PALS1 cortical pathology. Elimination of P53 completely rescued the number of CC3+ apoptotic cells and cells with double-strand DNA damage labeled by γH2AX, highlighting the importance of P53 activation in the pathological features of PALS1-deficiency that result in neural cell loss (Fig. 4a–d, Supplementary Fig. 3e-h). Apical progenitor numbers (PAX6+) were also fully rescued by Trp53 co-deletion, and intermediate progenitor and neuron numbers were significantly, though not completely, salvaged (Fig. 4e, f, Supplementary Fig. 4, 9). Next, we tested whether improved progenitor and neuron survival would restore cortical size and ameliorate microcephaly. Indeed, at postnatal day (P) 21, Trp53 co-deletion significantly rescued both cortical surface area and cortical thickness in the Pals1 cKO with Emx1-Cre, in which the neocortex and hippocampus would otherwise be completely ablated (Fig. 4g–j, Supplementary Fig. 10). In animals heterozygous for Pals1, Trp53 deletion restored cortical size nearly to WT levels, and remarkably, a small and disorganized, but distinct, hippocampus formed in the double mutants. Importantly, while Trp53 deletion was able to create a dramatic rescue effect in cortical size and neuronal numbers in Pals1 mutants, it was unable to restore disrupted apical polarity complex localization upon PALS1 reduction (Supplementary Fig. 11). Altogether, our data support P53 activation as the major contributor to the massive apoptosis and neuronal loss that cause microcephaly, and to the development of CIC structures and mitotic defects resulting from PALS1 loss.
Discussion
Our results demonstrate that entosis can be involved in the pathogenesis of microcephaly. It is unknown whether entosis in Pals1 mutants is identical to typical entosis found in cancer cells in which live cells are engulfed by host cells. We often observed that Pals1 mutant engulfed cells are small and contain micronuclei although we also occasionally observed full-size engulfed cells (Fig. 1b). We posit that our imaging timeline may include cells that have already undergone rounds of mitosis resulting in severe structural and numeric chromosomal abnormalities. Alternatively, engulfed cells are reduced over time due to autophagic clearance. Remarkably, entosis in the Pals1 mutants shares important features with entosis found in cancer cell lines. First, entosis is a dynamic, rather than static, process in which cells can be engulfed, retained, and released from host cells. Second, CIC structures in Pals1 mutants can interfere with host cell cytokinesis, which is a well-established consequence of entosis that can produce polyploidy or genomic instability2,4,5,9. Third, ROCK inhibition can completely abolish CIC structures, suggesting the essential role of Rho-ROCK signaling in this entosis, as in cancer cells. Finally, the involvement of P53 in clearing aneuploid cells by entosis is another essential feature shared by PALS1-dependent entosis and tumor cell lines. A previous study has shown that P53-mediated inhibition of Rho-ROCK activity at the contact site between host and engulfed cells generates an asymmetric increase in activity in the back end of engulfed cells14. Furthermore, in small-cell lung cancer cells, entosis is promoted only in P53 gain of function mutants, not in loss of function mutants or with WT P5315. Therefore, our study extends the understanding of the role of P53 in entosis by demonstrating its more direct ability to promote myosin activation in Pals1 mutants than has been found in earlier cell culture studies.
The current study provides an important clue as to how Pals1 mutation causes such a dramatic phenotype as the complete absence of the cerebral cortex and hippocampus. PALS1 acts as a scaffold linking the tight junction-associated proteins PATJ and MUPP1 to transmembrane CRB proteins and interacts with the other apical polarity complex proteins, PAR3/PAR6/aPKC43,44. Because overexpression of the basal complex protein LGL1 or knockdown of PAR3 causes entosis in MDCK cell culture by altering cellular actomyosin contractility and because CRB-aPKC is known to play a role in ROCK inhibition, we propose that PALS1-dependent polarity defects can result in abnormal Rho-ROCK activation underlying the initiation of entosis45,46,47,48. Intriguingly, despite their role in Rho-ROCK regulation and the ability to generate CIC in culture, mutations of genes encoding polarity complex proteins and interacting proteins such as CDC42 do not cause severe microcephaly in mice49,50,51,52. This suggests that the occurrence of entosis may be minimal in these mutants if it occurs at all. Similarly, P53 activation is found in many microcephaly models, but entosis has not been reported, likely due to lower-level or absent entosis. However, the difficulty in the detection of CIC in conventional imaging without membrane labeling cannot be ruled out. We speculate that the P53 activation caused by mitotic delay and abnormal chromosomal segregation may need to be combined with polarity defects to result in entosis. It is possible that only Pals1 mutants offer this rare combination that results in distinct microcephaly. Future studies can test whether P53 activation combined with polarity complex defects mimic the Pals1 phenotype. It will also be important to examine the contribution of P53 activation or polarity complex defects separately to determine the potential sufficiency of either of these events to cause entosis in cortical progenitors.
Our study provides a distinct pathogenic mechanism of microcephaly and a previously unidentified function for P53 activation in entosis in neural progenitors. From our results, we propose a model explaining how cellular events evolve to generate CIC structures and lead to microcephaly (Supplementary Fig. 12). Because we observed prolonged mitosis in Pals1 mutant cells regardless of the presence of CIC structures, although mitosis tended to be much longer in cells containing CIC structures, we propose that delayed mitosis is an initial pathogenic event. It is well established that increased mitotic length can cause structural chromosome defects, such as lagging chromosomes and micronuclei, as well as P53 activation. We postulate that PALS1 reduction activates Rho-ROCK, which causes lengthening of mitosis and chromosomal defects. Considering the known causal effects of mitotic delay on P53 activation, and because genetic elimination of Trp53 significantly but not completely shortens prolonged mitosis, this study suggests that mitotic delay precedes P53 activation in the chain of events. The presence of lagging chromosomes and micronuclei in PALS1-deficient cells may drive P53-dependent entosis as an effort to clear “unfit” aneuploid cells whereby some mitotic divisions result in daughter cell engulfment of “loser” cells that have chromosomal defects. Similarly, P53 activation-mediated entosis is found in multiple cell lines to selectively target non-diploid cells9. We posit that P53 activation drives entosis through Rho-ROCK hyperactivation as pMLC levels are significantly reduced by Trp53 genetic deletion. As we have observed persistent CIC in cells undergoing mitosis, retained entotic structures can further increase mitotic length by prohibiting the progression of cytokinesis. This exacerbates P53 activation in neural progenitors progressing through or exiting the cell cycle, reducing their viability, and promoting elimination through apoptosis. Accordingly, we observed massive apoptotic cell death and microglia activation throughout the developing cortex in the Pals1 mutants (Fig. 3c, d, Fig. 4a–d, Supplementary Fig. 3).
Because our studies are limited to observations of cells at the ventricular surface and do not include cells that shift basally upon interkinetic nuclear migration after mitosis, we could not trace cells with entotic structures through the full cell cycle. Future studies are necessary to clarify the effects of entosis on both inner and outer cell fate, such as the role of autophagy in eliminating CIC structures or the potential for outer cells to undergo cell death or cell cycle exit after division. Importantly, because many genetic causes of microcephaly have been linked to P53 activation, it is possible that entosis may contribute to their pathogenesis. Further studies will test whether this devastating pathogenic mechanism is shared by other genes and environmental factors that cause microcephaly.
Methods
Mice
Animal experiments were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of Lewis Katz School of Medicine at Temple University (Protocol # 5059). Food and water were provided ad libitum and animals were kept on a 12-hour light/dark cycle. Animals were kept at ambient temperatures between 70 and 74 °C and humidity between 30% and 70%. In these experiments, Pals1fl/fl mice, hGFAP-Cre mice, Emx1-Cre mice, and Trp53fl/fl mice were used. For every experiment, 3–8 animals from each mouse line were analyzed. Sex differences are not a factor in experiments at embryonic timepoints and have no obvious effects on cortical development in these models. The Pals1fl/fl mice were generated30 and maintained in the lab. hGFAP-Cre mice were obtained from Jackson Lab (stock# 004600), and Emx1-Cre mice were obtained from Jackson Lab (stock# 005628)28,29. Trp53fl/fl mice were obtained from Dr. Joon Young Park and are available through the National Cancer Institute Mouse Repository (#01XC2)42. ROSA mTmG mice were obtained from Jackson Lab (Stock# 007676)53. All mice were genotyped accordingly.
Time-lapse Imaging
Mouse cortices were harvested at embryonic day (E)13.5 and cultured in cortical slice medium containing DMEM with 25% HBSS, 5% FBS, 1% N-2 supplement, 1% Penn/Strep, 1% Glutamax, 0.66% glucose, and 50 nM SiR-DNA dye (Spirochrome, SC007) at 37 °C overnight. The next day, cortices were dissected to reveal the apical surface of the cortex and placed in Matrigel Basement Membrane Matrix (Corning, 354234) in the center of a 35/10 mm dish with the apical surface facing upward. Cortices were cultured in Matrigel (Corning, 354234) for an hour at 37 °C to solidify the Matrigel. Time-lapse imaging was then performed using a confocal microscope (SP8, Leica). Z-stacks of images were taken at a step size of 5 μm every 5 or 10 min for 6 h for a 50 μm total thickness at the apical surface of the cortex. Time-lapse analysis was performed using LAS AF (Leica), and a minimum of 20 mitotic apical progenitor cells per sample were examined for mitotic length and the presence of entosis.
Determination of mitotic stages
Analysis of mitotic stages was performed using LAS AF (Leica). Prophase was defined as a cell with a green membrane present at the apical surface containing condensed chromatin relative to interphase cells. Metaphase was defined as a cell with DNA aligned at the center of the cell with green membrane. In time-lapse imaging, where clear alignment was not obvious, further condensation of DNA within the cell compared to prophase was used to determine the transition from prophase to metaphase. Anaphase was defined as a cell with an oblong green membrane containing a clear separation of DNA to two poles. In PALS1-deficient cells wherein DNA dye in time-lapse imaging may not clearly separate, elongation of the green membrane was used to determine anaphase. Telophase was defined as cells which have undergone membrane division with a clear separation between DNA and green membrane within two daughter cells.
Electron microscopy
For transmission electron microscopy, cortices at E13.5 were fixed in 3% glutaraldehyde and stored with Millonig’s buffer for 5 min, then replaced with 2% OsO4 for 1 h at 4 °C. Tissues were then washed with ddH2O for 5 min and dehydrated by sequential standard ethanol washes, followed by propylene oxide, 50% LX-112, 100% LX-112 incubation. Tissues were embedded in a flat mold in a 70 °C oven overnight for polymerization. Thin sections (120 nm) were cut and placed on a 150 mesh copper grid (EMS, Hatfield, PA, USA) and stained for 15 min with 2% uranyl acetate, then rinsed with ddH2O, stained for 5 min in Reynold’s lead citrate. Images were taken from the JOEL 1200 Transmission Electron Microscope at 60 kV and captured with the 1 k × 1 k Gatan Digital Imaging System (Electron Microscopy Laboratory, Department of Pathology, UTHSC, Houston, TX, USA).
ROCK inhibitor treatment
Timed pregnant dams were treated with 10 mg/kg of Y-27632 (Selleck Chemicals, S1049) by IP injection at E12.5. At E13.5, embryonic cortices were dissected and cultured overnight in 10 µM Y-27632 with SiR-DNA dye (Spirochrome, SC007) for time-lapse imaging. Time-lapse imaging was performed as described above in the E14.5 samples.
Apical Explant Staining
Dorsal cortices from E14.5 mice were dissected out and incubated in 4% paraformaldehyde at 4 °C overnight. After 24 h, samples were transferred to phosphate-buffered saline (PBS) and maintained at 4 °C until staining. Antigen retrieval was performed by incubating the samples in 1% SDS in PBS, followed by rinsing in PBS. Permeabilization was then performed by incubating samples in 0.1% Tritonx-100 in PBS, followed by PBS washes. Next, samples were incubated in primary antibodies with 5% normal goat serum at 4 °C overnight and washed again in PBS the next morning. Samples were incubated in secondary antibodies (Alexa Fluor 488 anti-chicken, Cy3 anti-mouse, Alexa Fluor 647 anti-rabbit) with 5% normal goat serum and Hoechst 33258 at room temperature for 1 h. Samples were washed in PBS two times before being mounted on glass slides with the apical face of the cortex oriented upward, and coverslipped using Fluoromount G. Finally, samples were imaged with a confocal microscope (SP8, Leica) in 0.5 μm z-stacks of a 20 μm thickness of the apical surface of the cortex. Image analysis was performed using LAS AF (Leica) and Photoshop (Adobe). Mitotic cell modeling was performed using Imaris software to create surfaces objects where samples showed DAPI-labeled DNA and either NMIIB-labeled cleavage furrow, or Survivin-labeled midbodies. Mitotic staging of cells at the apical surface was completed in PH3+ cells. The staging was completed as described above wherein prophase cells contained PH3 labeling and condensed chromatin, prometaphase cells displayed chromatin that had begun to condense further towards the cell center, metaphase cells had chromatin aligned at the central metaphase plate, and ana/telophase cells were in the process of undergoing separation. In static images, cells undergoing DNA separation were considered ana/telophase because once a clear separation into two cells occurs, these cells are no longer PH3+ and appear to be in interphase once more.
Immunohistochemistry
Tissue samples were embedded in paraffin and sliced into 7 μm sections. Prior to immunohistochemistry, samples were rehydrated in a series of xylene and ethanol washes and rinsed in distilled water. When cryo-sections were used for immunohistochemistry, tissue samples were embedded in Tissue-Tek OCT compound, and sliced into 30μm sections. Cryo-sections were post-fixed to slides in 4% paraformaldehyde for 30 min before being rinsed in PBS. Antigen retrieval was performed on both paraffin and cryo-sections by boiling samples in a solution of sodium citrate with Tween-20. Samples were then washed in phosphate-buffered saline (PBS). Samples were incubated in primary antibodies with 5% normal goat serum at 4 °C overnight and rinsed again in PBS the next morning. Samples were incubated in secondary antibodies (Alexa Flour 488 anti-mouse, Alexa Fluor 488 anti-chicken, Alexa Fluor 488 anti-rabbit, Alexa Fluor 488 anti-rat, Cy3 anti-rabbit, Cy3 anti-mouse, Alexa Fluor 647 anti-mouse, Alexa Flour 647 anti-rabbit) at a concentration of 1:200 with 5% normal goat serum and 1:500 Hoechst 33258 at room temperature for 3 h. Samples were washed in PBS four times before being mounted with coverslips using Fluoromount G. Finally, samples were imaged with a confocal microscope (SP8, Leica) and image analysis was performed using LAS AF (Leica) and Photoshop (Adobe).
Primary antibodies
aPKC (1:200; BD, 610107), Cleaved Caspase-3 (1:200; Cell Signaling Technology, 9661), CTIP2 (1:200; Abcam, ab28448), CUX1 (1:200; Proteintech, 11733-1-AP), F4/80 (1:200; Proteintech, 28463-1-AP), FOXP2 (1:200; Abcam, ab16046), GFP (1:200; Aves, GFP-1020), N-CADHERIN (1:500; BD, 610920), NMIIB (1:500; Biolegend, PRB-445P), PALS1 (1:200; Proteintech, 17710-1-AP), Pan-CRB (1:200, Obtained from Dr. Seo-Hee Cho, Sydney Kimmel Medical College, Thomas Jefferson University (Cho et al., 2012), PAX6 (1:200; Biolegend, 901301), PH3 (1:500; Millipore Sigma, H0412), pMLC (1:200; Abcam, ab2480), MPM2 (1:200; Cell Signaling, 05-368), SURVIVIN (1:200; Cell Signaling, 2808), TBR2 (1:200; Abcam, ab23345), γH2AX (1:200; Millipore, 05-636)
RNAScope
Recently sectioned, paraformaldehyde-fixed and paraffin-embedded samples were processed using an RNAScope Multiplex Fluorescent v2-Mm Assay Kit (Advanced Cell Diagnostics Inc. # 323136). P21 transcripts were detected using a probe designed to label mouse Cdkn1 mRNA (Mm-Cdkn1a-C2, Advanced Cell Diagnostics Inc. #408551-C2). Samples were imaged with a confocal microscope (SP8, Leica) and analysis of RNAScope particles was done using ImageJ.
Quantification and statistical analyses
Quantification, including cell counting, was performed manually on two non-consecutive sections from three to six animals per genotype. Counting was performed on a 250μm width of the cortex in the case of immunohistochemistry, or on a 250 μm2 area of the apical surface in the case of apical explant staining. Counting was accomplished using Photoshop (Adobe). Histological and cortical size analysis were performed using ImageJ. Quantification of RNAScope data was performed using ImageJ. Where appropriate, a Student’s t test, one-way ANOVA followed by a post-hoc Tukey test was used to determine the statistical significance of the data. Statistical analysis was performed using GraphPad Prism software version 9.1.0 for Windows, GraphPad Software, San Diego, California USA, www.graphpad.com.
Data availability
The datasets generated and analyzed during the current study are provided with this paper in the Supplementary Information and Source Data file. Source data are provided with this paper.
References
Sun, Q. et al. Competition between human cells by entosis. Cell Res. 24, 1299–1310 (2014).
Krishna, S. & Overholtzer, M. Mechanisms and consequences of entosis. Cell Mol. Life Sci. 73, 2379–2386 (2016).
Sharma, N. & Dey, P. Cell cannibalism and cancer. Diagn. Cytopathol. 39, 229–233 (2011).
Kisurina-Evgenieva, O. P. et al. Entosis and cell cycle in tumor cell culture. Cell Tiss. Biol 13, 8–17 (2019).
Krajcovic, M. et al. A non-genetic route to aneuploidy in human cancers. Nat. Cell Biol. 13, 324–330 (2011).
Tanimura, N. & Fujita, Y. Epithelial defense against cancer (EDAC). Semin Cancer Biol. 63, 44–48 (2020).
Li, Y., Sun, X. & Dey, S. K. Entosis allows timely elimination of the luminal epithelial barrier for embryo implantation. Cell Rep. 11, 358–365 (2015).
Durgan, J. et al. Mitosis can drive cell cannibalism through entosis. Elife 6, e27134 (2017).
Liang, J. et al. p53-dependent elimination of aneuploid mitotic offspring by entosis. Cell Death Differ. 28, 799–813 (2021).
Overholtzer, M. et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131, 966–979 (2007).
Durgan, J. & Florey, O. Cancer cell cannibalism: Multiple triggers emerge for entosis. Biochim Biophys. Acta Mol. Cell Res. 1865, 831–841 (2018).
Ning, X., Luo, T., Chen, Z. & Sun, Q. The physics for the formation of cell-in-cell structures. Curr. Mol. Med. 15, 867–872 (2015).
Wang, M. et al. Mechanical ring interfaces between adherens junction and contractile actomyosin to coordinate entotic cell-in-cell formation. Cell Rep. 32, 108071 (2020).
Rizzotto, D. & Villunger, A. P53 clears aneuploid cells by entosis. Cell Death Differ. 28, 818–820 (2021).
Mackay, H. L. et al. Genomic instability in mutant p53 cancer cells upon entotic engulfment. Nat. Commun. 9, 3070 (2018). Erratum in: Nat Commun. 9(1), 3540 (2018).
Hanzlik, E. & Gigante, J. Microcephaly. Children 4, 47 (2017).
Sgourdou, P. et al. Disruptions in asymmetric centrosome inheritance and WDR62-Aurora kinase B interactions in primary microcephaly. Sci. Rep. 7, 43708 (2017).
McNeely, K. C. & Dwyer, N. D. Cytokinesis and postabscission midbody remnants are regulated during mammalian brain development. Proc. Natl Acad. Sci. USA 117, 9584–9593 (2020).
Silver, D. L. et al. The exon junction complex component Magoh controls brain size by regulating neural stem cell division. Nat. Neurosci. 13, 551–558 (2010).
Pilaz, L. J. et al. Prolonged mitosis of neural progenitors alters cell fate in the developing brain. Neuron 89, 83–99 (2016).
Marjanović, M. et al. CEP63 deficiency promotes p53-dependent microcephaly and reveals a role for the centrosome in meiotic recombination. Nat. Commun. 6, 7676 (2015).
Little, J. N. & Dwyer, N. D. p53 deletion rescues lethal microcephaly in a mouse model with neural stem cell abscission defects. Hum. Mol. Genet. 28, 434–447 (2019).
Ha, G. H. et al. p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation. Cancer Res. 67, 7155–7164 (2007).
Marin Navarro, A. et al. p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids. Cell Death Dis. 11, 52 (2020).
Ghouzzi, V. E. et al. ZIKA virus elicits P53 activation and genotoxic stress in human neural progenitors similar to mutations involved in severe forms of genetic microcephaly. Cell Death Dis. 7, e2440 (2016). Erratum in: Cell Death Dis. 9(12), 1155 (2018).
McConnell, M. J. et al. Failed clearance of aneuploid embryonic neural progenitor cells leads to excess aneuploidy in the Atm-deficient but not the Trp53-deficient adult cerebral cortex. J. Neurosci. 24, 8090–8096 (2004).
Shi, L., Qalieh, A., Lam, M. M., Keil, J. M. & Kwan, K. Y. Robust elimination of genome-damaged cells safeguards against brain somatic aneuploidy following Knl1 deletion. Nat. Commun. 10, 2588 (2019).
Zhuo, L. et al. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31, 85–94 (2001).
Gorski, J. A. et al. Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J. Neurosci. 22, 6309–6314 (2002).
Kim, S. et al. The apical complex couples cell fate and cell survival to cerebral cortical development. Neuron 66, 69–84 (2010).
Cho, S. H. et al. Genetic ablation of Pals1 in retinal progenitor cells models the retinal pathology of Leber congenital amaurosis. Hum. Mol. Genet. 21, 2663–2676 (2012).
Park, J. Y. et al. The apical complex protein Pals1 is required to maintain cerebellar progenitor cells in a proliferative state. Development 143, 133–146 (2016).
Sterling, N. et al. De novo variants in MPP5 cause global developmental delay and behavioral changes. Hum. Mol. Genet. 29, 3388–3401 (2020).
Straight, S. W. et al. Loss of PALS1 expression leads to tight junction and polarity defects. Mol. Biol. Cell. 15, 1981–1990 (2004).
Krajcovic, M. & Overholtzer, M. Mechanisms of ploidy increase in human cancers: a new role for cell cannibalism. Cancer Res. 72, 1596–1601 (2012).
D’Avino, P. P. & Capalbo, L. Regulation of midbody formation and function by mitotic kinases. Semin Cell Dev. Biol. 53, 57–63 (2016).
Fededa, J. P. & Gerlich, D. W. Molecular control of animal cell cytokinesis. Nat. Cell Biol. 14, 440–447 (2012).
Zeng, C., Zeng, B., Dong, C., Liu, J. & Xing, F. Rho-ROCK signaling mediates entotic cell death in tumor. Cell Death Discov. 6, 4 (2020).
Ganem, N. J. & Pellman, D. Linking abnormal mitosis to the acquisition of DNA damage. J. Cell Biol. 199, 871–881 (2012).
Qin, Q. et al. A novel function for p53: regulation of growth cone motility through interaction with Rho kinase. J. Neurosci. 29, 5183–5192 (2009).
Croft, D. R. et al. p53-mediated transcriptional regulation and activation of the actin cytoskeleton regulatory RhoC to LIMK2 signaling pathway promotes cell survival. Cell Res. 21, 666–682 (2001).
Jonkers, J., Meuwissen, R., van der Gulden, H., Peterse, H., van der Valk, M. & Berns, A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29, 418–425 (2001).
Arai, Y. & Taverna, E. Neural progenitor cell polarity and cortical development. Front Cell Neurosci. 11, 384 (2017).
Su, W. H., Mruk, D. D., Wong, E. W., Lui, W. Y. & Cheng, C. Y. Polarity protein complex Scribble/Lgl/Dlg and epithelial cell barriers. Adv. Exp. Med Biol. 763, 149–170 (2012).
Wan, Q. et al. Regulation of myosin activation during cell-cell contact formation by Par3-Lgl antagonism: entosis without matrix detachment. Mol. Biol. Cell. 23, 2076–2091 (2012).
Oon, C. H. & Prehoda, K. E. Phases of cortical actomyosin dynamics coupled to the neuroblast polarity cycle. Elife 10, e66574 (2021).
Röper, K. Anisotropy of Crumbs and aPKC drives myosin cable assembly during tube formation. Dev. Cell. 23, 939–953 (2012).
Ishiuchi, T. & Takeichi, M. Willin and Par3 cooperatively regulate epithelial apical constriction through aPKC-mediated ROCK phosphorylation. Nat. Cell Biol. 13, 860–866 (2011).
Imai, F. et al. Inactivation of aPCKλ results in the loss of adherens junctions in neuroepithelial cells without affecting neurogenesis in mouse neocortex. Development 133, 1735–1744 (2006).
Dudok, J. J., Murtaza, M., Alves, C. H., Rashbass, P. & Wijnholds, J. Crumbs 2 prevents cortical abnormalities in mouse dorsal telencephalon. Neurosci. Res. 108, 12–23 (2016).
Liu, W. A. et al. PARD3 dysfunction in conjunction with the dynamic HIPPO signaling drives cortical enlargement with massive heterotopia. Genes Dev. 32, 763–780 (2018).
Peng, X. et al. Inactivation of Cdc42 in embryonic brain results in hydrocephalus with ependymal cell defects in mice. Protein Cell 4, 231–242 (2013).
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593–605, (2007).
Acknowledgements
The authors would like to thank Dr. Bethany Terry for her advice and assistance during the preparation of this manuscript, and all of the members of the Kim lab for their helpful input. We appreciate Dr. Joon Young Park for sharing Trp53 floxed mice. This research was funded by the following sources: Shriners Hospitals for Children Research (86100-PHI-16 and 85109-PHI-18 to S.K.); a National Institute of Neurological Disorders and Stroke grant (R01NS04038 to S.K.).
Author information
Authors and Affiliations
Contributions
N.A.S. performed the experiments, analyzed the data, and wrote the manuscript. J.Y.P. performed the preparation of transmission electron microscope samples and initial experiments upon which the study was conceived. R.P. aided in the experimental design for time-lapse imaging and apical staining techniques. S.H.C. aided in the conception of the study and figure formatting. S.K. conceived and supervised the study and cowrote the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
41467_2022_35719_MOESM3_ESM.mp4
Supplementary Movie. 1. Cell-in-cell structures found in PALS1-deficient progenitors have their own DNA surrounded by a cellular membrane.
Source data
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sterling, N.A., Park, J.Y., Park, R. et al. An entosis-like process induces mitotic disruption in Pals1 microcephaly pathogenesis. Nat Commun 14, 82 (2023). https://doi.org/10.1038/s41467-022-35719-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41467-022-35719-y
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.